Survival and treatment outcomes of metaplastic breast carcinoma: Single tertiary care center experience in Pakistan

Authors

Zarka Samoon, Aga Khan UniversityFollow
Madiha Beg, Aga Khan University
Romana Idress, Aga Khan UniversityFollow
Adnan Jabbar, Aga Khan UniversityFollow

Document Type

Article

Department

Haematology/Oncology; Radiation Oncology; Radiology; Pathology and Laboratory Medicine

Abstract

Background: Metaplastic breast carcinoma (MBC) is a rare disease with incidence of less than 1%. MBC present with a larger tumor size, less number of nodes involved, mostly undifferentiated triple negative tumors. We aimed to determine progression-free and overall survival and reported hospital-based incidence of MBC.
Material and Methods: A retrospective closed Cohort study elicited data of 42 patients with MBC from January 2008 to December 2013; followed till August 2016. Kaplan-Meier method was applied to compute overall and progression-free survival analysis. Cox Proportional hazard ratios were computed to assess associations between survival and independent variables.
Results: Hospital-based incidence of MBC was 1.92% (42/2187), 95% CI [1.41-2.56]. The median age at tumor diagnosis was 54 years (range, 25-81 years). Thirty-nine (92.9%) patients had Grade III tumor. The most common histopathology was squamous (69%). The median tumor size was 4.5 cm (range, 0.8-17 cm). Nineteen (45.2%) patients had nodal involvement at diagnosis. Four patients (9.5%) had metastatic disease at presentation. Hormone receptors were positive in 19 (45.2%) patients. Her-2 neu receptor was positive in 9 (19%) patients. Sixteen (38.1%) patients had triple negative disease. Neoadjuvant and adjuvant chemotherapy was received by 10 (31.25%) and 19 (45.2%) patients respectively. Both median progression-free and overall survival was 38 months.
Conclusion: Five-year progression-free and overall survival was 79.5% and 76.3%, respectively. We report better survival outcomes when compared to series described earlier despite our patient population presenting mostly with high grade, large tumors, and half of them exhibiting nodal and hormonal involvement.

Publication (Name of Journal)

Indian Journal of Cancer

Recommended Citation

Samoon, Z., Beg, M., Idress, R., Jabbar, A. (2019). Survival and treatment outcomes of metaplastic breast carcinoma: Single tertiary care center experience in Pakistan. Indian Journal of Cancer, 56(2), 124-129.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_radiat_oncol/73

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.